Multimodality therapy is recommended for limited-stage combined small cell esophageal carcinoma.
about
Survival benefit of radiotherapy to patients with small cell esophagus carcinoma: an analysis of Surveillance Epidemiology and End Results (SEER) dataA retrospective study on the prognostic value of preoperative neutrophil/lymphocyte ratio in patients with primary small-cell carcinoma of the esophagus.
P2860
Multimodality therapy is recommended for limited-stage combined small cell esophageal carcinoma.
description
2015 nî lūn-bûn
@nan
2015 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Multimodality therapy is recom ...... all cell esophageal carcinoma.
@ast
Multimodality therapy is recom ...... all cell esophageal carcinoma.
@en
type
label
Multimodality therapy is recom ...... all cell esophageal carcinoma.
@ast
Multimodality therapy is recom ...... all cell esophageal carcinoma.
@en
prefLabel
Multimodality therapy is recom ...... all cell esophageal carcinoma.
@ast
Multimodality therapy is recom ...... all cell esophageal carcinoma.
@en
P2093
P2860
P356
P1476
Multimodality therapy is recom ...... all cell esophageal carcinoma.
@en
P2093
Chao Jiang
Huan-Huan Wang
Lu-Jun Zhao
Mao-Bin Meng
Xian-Liang Zeng
Zhi-Qiang Wu
Zhi-Yong Yuan
P2860
P304
P356
10.2147/OTT.S76048
P407
P577
2015-02-13T00:00:00Z